Production of recombinant SLIT2 proteins

VB Vikrant K Bhosle
CS Chunxiang Sun
SP Sajedabanu Patel
TH Tse Wing Winnie Ho
JW Johannes Westman
DA Dustin A Ammendolia
FL Fatemeh Mirshafiei Langari
NF Noah Fine
NT Nicole Toepfner
ZL Zhubing Li
MS Manraj Sharma
JG Judah Glogauer
MC Mariana I Capurro
NJ Nicola L Jones
JM Jason T Maynes
WL Warren L Lee
MG Michael Glogauer
SG Sergio Grinstein
LR Lisa A Robinson
CR Carla V Rothlin
request Request a Protocol
ask Ask a question
Favorite

Large-scale production of bio-inactive human N-SLIT2ΔD2 was performed by transfecting FreeStyle 293-F cells with human N-SLIT2ΔD2 cDNA (1 ug/mL) using PEI reagent (Polyethyleneimine, linear, M.W. 25,000, Thermo Fisher Scientific) (Patel et al., 2012). After 5 days, the culture medium was loaded onto HisPur Ni-NTA resin (Thermo Fisher Scientific), washed with imidazole (35 mM), eluted with imidazole (250 mM), and desalted using a Pierce Zeba desalting column (7 K MWCO; Thermo Fisher Scientific). Protein molecular weight was determined by immunoblotting using anti-6XHIS-HRP conjugated antibody. Protein activity was assayed by using a spreading assay in RAW264.7 cells, as described previously (Bhosle et al., 2020). Recombinant human N-SLIT2 was purchased from PeproTech (Cranbury, NJ, USA). Endotoxin levels in all preparations were measured using ToxinSensor Chromogenic LAL Endotoxin Assay Kit (GenScript, Piscataway, NJ, USA) and were less than 0.05 EU/ml.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A